AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Anthropic launches powerful AI model Claude Sonnet 4.5, cementing its lead in coding and autonomous capabilities.
Investors explore penny stocks and small-caps amid market volatility, with diverse growth opportunities and risks to consider.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Anthropic launches powerful AI model Claude Sonnet 4.5, cementing its lead in coding and autonomous capabilities.
Investors explore penny stocks and small-caps amid market volatility, with diverse growth opportunities and risks to consider.
